Is vitamin D level important in pregnant women with COVID-19?

Değirmenci et al., Journal of Controversies in Obstetrics & Gynecology and Pediatrics, doi:10.51271/JCOGP-0035, Jul 2024
Hospitalization 43% improvement lower risk ← → higher risk HCQ for COVID-19  Değirmenci et al.  LATE TREATMENT Is late treatment with HCQ beneficial for COVID-19? Retrospective 125 patients in Turkey (March 2020 - January 2021) No significant difference in hospitalization c19early.org Değirmenci et al., J. Controversies in.., Jul 2024 0 0.5 1 1.5 2+ RR
HCQ for COVID-19
1st treatment shown to reduce risk in March 2020, now with p < 0.00000000001 from 424 studies, used in 59 countries.
No treatment is 100% effective. Protocols combine treatments.
6,200+ studies for 200+ treatments. c19early.org
Retrospective 125 pregnant women hospitalized with COVID-19 in Turkey, showing no significant difference in hospitalization length with HCQ, and longer hospitalization with lopinavir/ritonavir use.
Study covers HCQ, lopinavir/ritonavir, and vitamin D.
risk of hospitalization, 42.8% lower, OR 0.57, p = 0.76, treatment 10, control 115, RR approximated with OR.
Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates
Değirmenci et al., 30 Jul 2024, retrospective, Turkey, peer-reviewed, mean age 29.3, 7 authors, study period March 2020 - January 2021. Contact: mulayimsizer@hotmail.com.
$0 $500 $1,000+ Efficacy vs. cost for COVID-19 treatment protocols c19early.org November 2025 Turkey United Kingdom Russia USA Sudan Angola Colombia Kenya Mozambique Pakistan Argentina Vietnam Peru Philippines Spain Brazil Italy France Japan China Uzbekistan Nepal Ethiopia Iran Ghana Mexico South Korea Germany Bangladesh Saudi Arabia Algeria Morocco Poland DR Congo Madagascar Thailand Uganda Venezuela Nigeria Egypt Bolivia Taiwan Zambia Fiji Bosnia-Herzegovina Ukraine Côte d'Ivoire Bulgaria Greece Slovakia Singapore Iceland New Zealand Czechia Mongolia Israel Trinidad and Tobago Hong Kong North Macedonia Belarus Qatar Panama Serbia CAR Chad Turkey favored low-cost treatments.The average efficacy of treatments was moderate.Low-cost treatments improve early treatment, andprovide complementary/synergistic benefits. More effective More expensive 75% 50% 25% ≤0%
$0 $500 $1,000+ Efficacy vs. cost for COVID-19treatment protocols worldwide c19early.org November 2025 Turkey United Kingdom Russia USA Sudan Angola Colombia Kenya Mozambique Pakistan Argentina Vietnam Peru Philippines Spain Brazil Italy France Japan China Uzbekistan Nepal Ethiopia Iran Ghana Mexico South Korea Germany Bangladesh Saudi Arabia Algeria Morocco Poland India DR Congo Madagascar Thailand Uganda Venezuela Nigeria Egypt Bolivia Taiwan Zambia Fiji Ukraine Côte d'Ivoire Eritrea Bulgaria Greece Slovakia Singapore New Zealand Czechia Mongolia Israel Trinidad and Tobago North Macedonia Belarus Qatar Panama Serbia Syria Turkey favored low-cost treatments.The average efficacy was moderate.Low-cost protocols improve early treatment,and add complementary/synergistic benefits. More effective More expensive 75% 50% 25% ≤0%
DOI record: { "DOI": "10.51271/jcogp-0035", "ISSN": [ "2980-0579" ], "URL": "http://dx.doi.org/10.51271/JCOGP-0035", "abstract": "<jats:p>Aims: The Covid-19 pandemic started in Wuhan City, Hubei Province, China in late December 2019. In our study, we aimed to evaluate the effectiveness of vitamin D levels on the clinic of the disease, laboratory findings, severity of the disease and, length of hospital stay by grouping pregnant patients with a diagnosis of Covid-19 according to their vitamin D levels.\nMethods: A total of 125 patients were included. According to the vitamin D levels of the patients at the time of hospitalization, two groups were determined as below and above 20ng/ml, which is the limit of vitamin D deficiency. The patients in these two groups were compared in terms of demographic features, clinical findings, laboratory findings, imaging findings, hospitalization times and need for intensive care.\nResults: When evaluated according to serum 25 hydroxyvitamin D level, patients’ fever, pulse, oxygen saturation, the severity of lung involvement in computed tomography, hospitalization there was no statistically significant difference between the groups in terms of duration and need for intensive care. When the laboratory parameters of the patients at hospitalization were compared according to serum 25 hydroxyvitamin D levels, there was no statistically significant difference between the two groups in terms of any laboratory parameter. As a result of the analysis, only lymphocyte count was determined as the independent variable affecting the severity of lung involvement in thorax CT (Computed tomography). As the lymphocyte count decreased, the severity of involvement in thorax CT increased.\nConclusion: Our study showed that vitamin D level did not have a significant relationship with any of the parameters related to Covid-19 such as clinical and laboratory findings, severity of the disease and duration of hospitalisation. It is also supported by our study that the decrease in lymphocyte counts is associated with severe Covid-19 disease.</jats:p>", "author": [ { "ORCID": "http://orcid.org/0000-0003-4685-3335", "affiliation": [], "authenticated-orcid": false, "family": "Değirmenci", "given": "Ahmet", "sequence": "first" }, { "ORCID": "http://orcid.org/0000-0002-9306-6281", "affiliation": [], "authenticated-orcid": false, "family": "Ayçiçek", "given": "Sertaç", "sequence": "additional" }, { "ORCID": "http://orcid.org/0000-0001-9142-6127", "affiliation": [], "authenticated-orcid": false, "family": "Fındık", "given": "Fatih Mehmet", "sequence": "additional" }, { "ORCID": "http://orcid.org/0000-0003-4864-7287", "affiliation": [], "authenticated-orcid": false, "family": "Sizer", "given": "Mulaim", "sequence": "additional" }, { "ORCID": "http://orcid.org/0009-0006-1602-4009", "affiliation": [], "authenticated-orcid": false, "family": "Değirmenci", "given": "Azize Pervin", "sequence": "additional" }, { "ORCID": "http://orcid.org/0000-0003-0108-2856", "affiliation": [], "authenticated-orcid": false, "family": "Değirmenci Ayçiçek", "given": "Pelin", "sequence": "additional" }, { "ORCID": "http://orcid.org/0000-0003-1836-6281", "affiliation": [], "authenticated-orcid": false, "family": "Mermutluoğlu", "given": "Çiğdem", "sequence": "additional" } ], "container-title": "Journal of Controversies in Obstetrics &amp; Gynecology and Pediatrics", "container-title-short": "JCOGP", "content-domain": { "crossmark-restriction": false, "domain": [] }, "created": { "date-parts": [ [ 2024, 8, 8 ] ], "date-time": "2024-08-08T06:06:54Z", "timestamp": 1723097214000 }, "deposited": { "date-parts": [ [ 2024, 8, 8 ] ], "date-time": "2024-08-08T06:06:57Z", "timestamp": 1723097217000 }, "indexed": { "date-parts": [ [ 2024, 8, 9 ] ], "date-time": "2024-08-09T00:10:17Z", "timestamp": 1723162217242 }, "is-referenced-by-count": 0, "issue": "3", "issued": { "date-parts": [ [ 2024, 7, 30 ] ] }, "journal-issue": { "issue": "3", "published-online": { "date-parts": [ [ 2024, 7, 30 ] ] } }, "member": "28304", "original-title": [], "page": "51-57", "prefix": "10.51271", "published": { "date-parts": [ [ 2024, 7, 30 ] ] }, "published-online": { "date-parts": [ [ 2024, 7, 30 ] ] }, "publisher": "MediHealth Academy", "reference-count": 0, "references-count": 0, "relation": {}, "resource": { "primary": { "URL": "http://journal-jcogp.com/Publication/DisplayArticle/27358" } }, "score": 1, "short-title": [], "source": "Crossref", "subject": [], "subtitle": [], "title": "Is vitamin D level important in pregnant women with COVID-19?", "type": "journal-article", "volume": "2" }
Late treatment
is less effective
Please send us corrections, updates, or comments. c19early involves the extraction of 200,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. IMA and WCH provide treatment protocols.
  or use drag and drop   
Submit